↓ Skip to main content

Dove Medical Press

The Benefits of Molnupiravir Treatment in Healthcare Facilities Patients with COVID-19

Overview of attention for article published in Drug Design, Development and Therapy, January 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
19 Mendeley
Title
The Benefits of Molnupiravir Treatment in Healthcare Facilities Patients with COVID-19
Published in
Drug Design, Development and Therapy, January 2023
DOI 10.2147/dddt.s392708
Pubmed ID
Authors

Shih-Lung Cheng, Ping-Huai Wang, Cheng-Yu Chang, Hsu-Hui Wang, Chung-Jen Wang, Kuan-Ming Chiu

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 11%
Unspecified 1 5%
Student > Bachelor 1 5%
Other 1 5%
Student > Ph. D. Student 1 5%
Other 1 5%
Unknown 12 63%
Readers by discipline Count As %
Medicine and Dentistry 2 11%
Nursing and Health Professions 2 11%
Unspecified 1 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Chemistry 1 5%
Other 1 5%
Unknown 11 58%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 January 2023.
All research outputs
#20,216,385
of 25,707,225 outputs
Outputs from Drug Design, Development and Therapy
#1,326
of 2,278 outputs
Outputs of similar age
#336,523
of 479,289 outputs
Outputs of similar age from Drug Design, Development and Therapy
#13
of 36 outputs
Altmetric has tracked 25,707,225 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,278 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 479,289 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 36 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.